๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

COST-MINIMISATION ANALYSIS VERSUS COST-EFFECTIVENESS ANALYSIS, REVISITED

โœ Scribed by Helen Dakin; Sarah Wordsworth


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
211 KB
Volume
22
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Domiciliary clinics II: a cost minimisat
โœ Carmelo Aquilina; David Anderson ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 1 views

## Abstract ## Objectives We compare the cost of assessing new referrals to an old age psychiatry service at the patient's home or a hospitalโ€based clinic. ## Method An old age psychiatry service in Liverpool where routine referrals were assessed at home (domiciliary clinic) was compared to an a

Modelling for cost-effectiveness analysi
โœ Louise B. Russell ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB ๐Ÿ‘ 1 views

A model creates the framework for a cost-e!ectiveness analysis, allowing decision makers to explore the implications of using an intervention in di!erent ways and under di!erent conditions. To serve its purpose a model must produce accurate predictions and allow for substantial variation in the fact

Cost-effectiveness analysis with risk av
โœ Joshua Graff Zivin ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 80 KB ๐Ÿ‘ 1 views

## Abstract This paper discusses why, in a medical context, the standard assumption of a riskโ€neutral social planner is inappropriate and develops a framework for conducting costโ€effectiveness (CE) analysis when social planners are riskโ€averse. This framework demonstrates that if new medical interv

Longevity bias in cost-effectiveness ana
โœ Liqun Liu; Andrew J. Rettenmaier; Thomas R. Saving ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 1 views

## Abstract We use a simple lifetime utility maximization model to study the problem of medical resource allocation. This model leads to a welfare specification with a QALY (qualityโ€adjusted lifeโ€year) component that captures an individual's preferences over both life expectancy and health status.

Bayesian cost-effectiveness analysis wit
โœ Miguel A. Negrรญn; Francisco J. Vรกzquez-Polo ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 263 KB ๐Ÿ‘ 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d